PUBLICATIONS

Original Research

  1. The impact of different scenarios for intermittent bladder catheterization on health state utilities: results from an internet-based time trade-off survey. J Med Econ. 2018 Jun 8:1-17. [Acknowledged for editorial assistance]
  2. A Comparison of AMSTAR and ROBIS tools for Methodological Quality Assessment of Systematic reviews of Alzheimer’s Disease at ISPOR 23rd Annual International Meeting, May 19-23, 2018, Baltimore, MD, USA   [In-House Publication]
  3. Using the Time Trade Off (TTO) Surveys to Measure Health Utilities Associated With Different Urinary Catheter Innovations at ISPOR 23rd Annual International Meeting, May 19-23, 2018, Baltimore, MD, USA  [Acknowledged for editorial assistance]
  4. Cost-effectiveness of hydrophilic-coated intermittent catheters compared with uncoated catheters in Canada: a public payer perspective. J Med Econ. 2018 Mar 15:1-10. [Acknowledged for editorial assistance]
  5. Analysis of Retracted Systematic Reviews and Meta Analysis a Retrospective Cross Sectional Study at 2nd Indian Medical Affairs Summit, March 10, 2018, Mumbai, India   [In-House Publication]
  6. The Health-Related Quality of Life (HRQoL) Associated with Ostomy Appliances and Features A Time Trade-off (TTO) Internet Experiment at ISPOR 20th Annual European Congress, 4 – 8 November 2017, Glasgow, Scotland   [Acknowledged for editorial assistance]
  7. Validity of Simplified Ankylosing Spondylitis Disease Activity Scores (SASDAS) in Indian Ankylosing Spondylitis Patients. J Clin Diagn Res. 2017;11(9):OC06-OC09. [Acknowledged for statistical analysis, preparation, processing and submission of manuscript]
  8. Symptomatic Isolated Terminal Ileal Ulcers: Etiology and Clinical Significance. Endosc Int Open. 2017;5(7):E539-E546. [Acknowledged for editing of the manuscript]
  9. Biologics Use in Asian Indian Patients with Ankylosing Spondylitis: A Physician’s Perspective. J Clin Diagn Res. 2016;10(7):OC29-32. [Acknowledged for statistical analysis, preparation, processing and submission of manuscript]
  10. Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis. Lupus. 2016 Apr;25(5):525-31. [Acknowledged for manuscript preparation]
  11. Can thyroid volume predict thyroid dysfunction in patients with systemic sclerosis? A prospective cross-sectional study from a tertiary care center in North West IndiaClinical Rheumatology. 35, (3): 765–769 [Assisted in publication management] 
  12. Experience of biological agents usage in patients with rheumatoid arthritis from a Western Indian center. Indian J Rheumatol 2016;11:22-6. [Acknowledged for statistical analysis, preparation, and processing of manuscript] 
  13. Acarbose improves glycemic control as add-on or monotherapy in Indian type-2 diabetes: Findings from the GlucoVIP multinational observational study. Indian J Endocrinol Metab. 2013;17(Suppl 3):S674-9. [Acknowledged for editorial assistance] 
  14. Effectiveness and safety of fixed dose combination of acarbose/metformin in Indian Type 2 diabetes patients: Results from observational GLOBE Study. Indian J Endocrinol Metab. 2015;19(1):129-35. [Acknowledged for editorial assistance] 
  15. Current Clinical Practice Scenario of Osteoporosis Management in IndiaJ Clin Diagn Res. 2015 Oct; 9(10): RC04–RC08. [Acknowledged for manuscript preparation] 
  16. A post-marketing study evaluating the lipid-altering efficacy and safety of approved dose ranges of rosuvastatin in Indian hyperlipidemia patients in routine clinical practice (ROSUVEES). JICC 2015;5(4): 282-290 [Acknowledged for manuscript editing and publication management] 
  17. Therapeutic Effects of Oral Nutritional Supplements during Haemodialysis: Physician’s Experience. J Assoc Physicians India. 2014;62(12):30-4. [Assisted in manuscript preparation and publication management] 
  18. Impact of supplementing preoperative intravenous omega 3 Fatty acids in fish oil on immunomodulation in elderly patients undergoing hip surgery. Indian J Surg. 2013 ;75(6):478-84. [Assisted in manuscript preparation and publication management]
  19. Early Goal Directed Nutrition Support: Does It Impact Outcome in Critically Ill Patients? Clinical Nutrition. 2013; 32 (1): S127–S128
  20. Role of Voglibose in the Treatment of Prediabetes in Indian Population: A Cross-Speciality Survey. J Clin Diagn Res. 2013 Oct; 7(10): 2258–2260.
  21. Efficiency and mechanism of intracellular paclitaxel delivery by novel nanopolymer-based tumor-targeted delivery system, Nanoxel(TM). Clin Transl Oncol. 2013;15(1):26-32. [Assisted in manuscript preparation and publication management] 
  22. A comparative analysis on the efficacy and safety of intaxel® and taxol® in advanced metastatic breast cancer. J Clin Diagn Res. 2013 Jun;7(6):1120-4. [Assisted in manuscript preparation and publication management] 

Review Articles and Case Reports

  1. Chikungunya: A rheumatologist’s perspective. Int J Rheum Dis. 2018 Mar;21(3):584-601. 
  2. Blood Pressure Variability in Patients with Diabetes Mellitus with Hypertension: Treatment Recommendations and Role of Amlodipine. J Assoc Physicians India. 2017 Mar;65(3):67-71. 
  3. Significance of BP Control in Reducing Stroke Events: Role of Amlodipine in an Indian Perspective. J Assoc Physicians India. 2016 ;64(9):49-52. 
  4. Safety of Nicergoline as an Agent for Management of Cognitive Function Disorders. Biomed Res Int. 2014; 2014: 610103. 
  5. Combination Therapy of Albumin-Bound Paclitaxel and Carboplatin as First Line Therapy in a Patient with Ovarian Cancer. Case Rep Oncol Med. 2014; 2014: 940591. 
  6. Nab-Paclitaxel in Patients with Advanced Pancreatic Cancer: Case Series. JCR 2014;4:295-299 

Systematic Reviews/Meta-Analysis

  1. Efficacy and Safety of Everolimus as a Combination Therapy in the Treatment of Metastatic Breast Cancer: A Systemic Review and Meta-analysis at ISPOR 23rd Annual International Meeting, May 19-23, 2018, Baltimore, MD, USA  [Finalist Poster Presentation Category]
  2. Efficacy and Safety of Vedolizumab in the Treatment of Ulcerative Colitis: A Systemic Review and Meta-analysis at ISPOR 23rd Annual International Meeting, May 19-23, 2018, Baltimore, MD, USA  [Finalist Poster Presentation Category]
  3. Efficacy and Safety of Enzalutamide in Metastatic Prostate Cancer Patients: A Systematic Review and Meta-Analysis at ISPOR 23rd Annual International Meeting, May 19-23, 2018, Baltimore, MD, USA 
  4. Efficacy and Safety of Nilutamide in Metastatic Prostate Cancer Patients who Underwent Orchiectomy: A Systematic Review and Meta-analysis at CPCON 3rd International Conference on Clinical Pharmacy, Jan 21-22, 2018, Manipal, Mangaluru, India 
  5. Efficacy and Safety of Donepezil in Patients with Alzheimer’s disease: A Systematic Review and Meta-analysis at CPCON 3rd International Conference on Clinical Pharmacy, Jan 21-22, 2018, Manipal, Mangaluru, India 
  6. Efficacy and Safety of Oxaliplatin/Capecitabine Based Chemotherapy Plus Bevacizumab as First-line Treatment for Advanced Colorectal Cancer: A Systematic Review and Meta analysis at ISPOR 22nd Annual International Meeting, May 20-24, 2017, Boston, MA, USA 
  7. Efficacy and Safety of Bevacizumab Plus Chemotherapy Versus Chemotherapy Alone in the Treatment of NSCLC in Asian Patients: A Systematic Review and Meta analysis at ISPOR 22nd Annual International Meeting, May 20-24, 2017, Boston, MA, USA 
  8. Cardiovascular Safety of Saxagliptin in Patients With Type 2 Diabetes Mellitus: A Systematic Review And Meta-analysis at ISPOR 19th Annual European Congress, 29 October-2 November 2016, Vienna, Austria
  9. Safety Profile of Daclizumab for the Treatment of Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta Analysis at ISPOR 19th Annual European Congress, 29 October-2 November 2016, Vienna, Austria
  10. Systematic Review and Meta-analysis of Risperidone for the Treatment of Schizophrenia at ISPOR 19th Annual European Congress, 29 October-2 November 2016, Vienna, Austria 
  11. Mepolizumab for the Treatment of Chronic Asthma. A Meta-Analysis of Randomized Placebo-Controlled Trials at ISPOR 7th Asia-Pacific Conference, May 3-6, 2016, Singapore. 
  12. Efficacy and Safety of Dulaglutide in the Management of Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Controlled Trials at ISPOR 21st Annual International Meeting, May 21-25, 2016, Washington, DC, USA. [Finalist Poster Presentation Category]  
  13. Systematic Review and Meta-analysis of Briakinumab, a Fully Human Interleukin 12/23 Monoclonal Antibody, for the Treatment of Moderate to Severe Chronic Plaque Psoriasis at ISPOR 21st Annual International Meeting, May 21-25, 2016, Washington, DC, USA. 
  14. Investigating the Value of Omalizumab in the Treatment of Severe Persistent Allergic Asthma: A Systematic Review of Cost- Effectiveness Studies at ISPOR 21st Annual International Meeting, May 21-25, 2016, Washington, DC, USA.  
  15. Current Pharmacological Treatment Options and Management of Guillain-Barre Syndrome (GBS): An Updated Systematic Review at 1st National Conference on Health Technology Assessment, 22nd January 2016 at Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  16. Efficacy and safety of canagliflozin among patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Indian J Endocr Metab 2015;19:705-21
  17. Phytomedicine in the Treatment of Cancer: A Health Technology Assessment. J Clin Diagn Res. 2015 Dec; 9(12): XC04–XC09.
  18. Mammography for Breast Cancer Screening in India – A Health Technology Assessment at ISPOR 18 Annual European Congress, 7-11 November, 2015, Milan, Italy. 
  19. Comparison of T-piece Resuscitator with Other Flow – Inflating Bags for Providing Positive Pressure Ventilation During Neonatal Resuscitation: A Systematic Review at ISPOR 18 Annual European Congress, 7-11 November, 2015, Milan, Italy. 
  20. The Use of Mobile Health Technology in Promoting Infant Vaccine Adherence – a Health Technology Assessment at ISPOR 18 Annual European Congress, 7-11 November, 2015, Milan, Italy. 
  21. Impact of Socioeconomic Status on the Prevalence of Complications in Type 2 Diabetes in Indian Population: a Systematic Review at ISPOR 18 Annual European Congress, 7-11 November, 2015, Milan, Italy. 
  22. Risk of Fracture in Type 2 Diabetes Mellitus Patients: Meta-analysis of Observational Studies at ISPOR 18 Annual European Congress, 7-11 November, 2015, Milan, Italy. 
  23. Physical Functioning and Pain in Chronic Low Back Pain: A Systematic Review of Psychometric Properties of Various Outcomes Measures at ISPOR 18 Annual European Congress, 7-11 November, 2015, Milan, Italy. 
  24. The Impact Of Severe Asthma On The Quality Of Life: A Systematic Review at ISPOR 18 Annual European Congress, 7-11 November, 2015, Milan, Italy. 
  25. Epidemiology And Current Treatment Of Neuromyelitis Optica: A Systematic Review at ISPOR 18 Annual European Congress, 7-11 November, 2015, Milan, Italy. 
  26. Impact of Community Based Therapy on Children With Mental Health Disorders: A Health Technology Assessment at ISPOR 20th Annual International Meeting, May 16 – 20, 2015, Philadelphia, PA, USA. 
  27. Efficacy And Safety Of Canagliflozin Among Patients With Type 2 Diabetes Mellitus: A Systematic Review And Meta-Analysis at ISPOR 20th Annual International Meeting, May 16 – 20, 2015, Philadelphia, PA, USA. 
  28. The Prevalence of Age-related Macular Degeneration (AMD) in Indian Population: A Systematic Review at ISPOR 20th Annual International Meeting, May 16 – 20, 2015, Philadelphia, PA, USA. 
  29. Association Between Bone Mineral Density and Type 1 Diabetes Mellitus: A Meta-analysis Of Observational Studies at ISPOR 20th Annual International Meeting, May 16 – 20, 2015, Philadelphia, PA, USA. 
  30. Quality of Life in Neuromyelitis Optica: A Systematic Review at ISPOR 20th Annual International Meeting, May 16 – 20, 2015, Philadelphia, PA, USA. 
  31. Safety of Nicergoline as an Agent for Management of Cognitive Function Disorders. Biomed Res Int. 2014; 2014: 610103. [Assisted in medical writing and publication management] 

Healthcare Use and Policy

  1. Adaptive Licensing and Real World Evidence (RWE) at ISPOR 23rd Annual International Meeting, May 19-23, 2018, Baltimore, MD, USA 
  2. Role of Social Media in Patient Reported Outcomes (PRO) Research at DIA Global Annual Meeting, June 24-28, 2018, Boston, MA, USA 
  3. Taking Patients as Partners in Research at ISPOR 22nd Annual International Meeting, May 20-24, 2017, Boston, MA, USA 
  4. The Emerging Role of Patient Reported Outcomes (PROs) in Clinical Trials: An Indian Perspective. Value in Health 2017; 12:24-26
  5. Patient Advocacy and Changing Paradigm in Drug Access. Int J Med Public Health 2016;6:179-18
  6. Real world evidence: An Indian perspective. Perspect Clin Res 2016;7:156-60
  7. Can Health Technology Assessment (HTA) provide a solution to tackle the increasing health-care expenditure in India?. Indian J Public Health 2016;60:138-41
  8. The value of observational study data in healthcare decision making: An Indian perspective. Int J Med Public Health 2016;6:53-5
  9. Importance of Economic Evaluation in Health Care: An Indian Perspective. Value in Health Regional Issues. 2016;9:78-83
  10. Comparative effectiveness research and its utility in In-clinic practice. Perspect Clin Res 2016;7:9-14
  11. Improving Access to New Treatments with Value Based Pricing: An Indian Perspective. Pharmacology, Toxicology and Biomedical Reports. 2016;2(1):1-5
  12. Stratified Medicine: Will it be the Future of Medicine? Pharmacology, Toxicology and Biomedical Reports. 2016;2(1):11-14
  13. Patient Advocacy and Changing Paradigm in Drug Access at ISPOR 21st Annual International Meeting, May 21-25, 2016, Washington, DC, USA.  
  14. Patient Centric Clinical Trials – The Future of Clinical Trials at 9th Annual Conference of ISCR (Indian Society for Clinical Research) January 8th & 9th, 2016, Mumbai. 
  15. Diagnostic Accuracy of Xpert Test in Tuberculosis Detection: A Systematic Review and Meta-analysis. J Glob Infect Dis. 2016 Jan-Mar; 8(1): 32–40.
  16. Utilizing Patient Registries as Health Technology Assessment (HTA) tool. Sys Rev Pharm 2015, 6 (1):5-8
  17. The Role of Patient Reported Outcomes (PROs) in Healthcare Policy Making. Sys Rev Pharm 2015, 6 (1):1-5
  18. The Value of Big Data in Clinical Decision Making. International Journal of Computer Science and Information Technologies, Vol. 6 (4) , 2015, 3830-3835
  19. The emerging role of patient-centered outcomes research in shaping the future of healthcare delivery in India: A brief review. Int J Med Public Health 2015;5:125-7
  20. Role of a medical advisor in pharmacovigilance as a business support service. Perspect Clin Res 2015;6:64-7
  21. How Insurance Claim Data can Help in Health Outcomes Research: An Indian Perspective at ISPOR 18 Annual European Congress, 7-11 November, 2015, Milan, Italy. 
  22. The Role of Patient Reported Outcomes (PROs) in Healthcare Policy Making at Fourth International Conference of Pharmacoecomomics & Outcomes Research. October 31 – November 1, 2015, New Delhi, India. 
  23. The Real World: How Integrated data can be used to improve patient care? at Indo-Global Healthcare Summit & Expo 2015. 23 – 26 July, 2015, Hyderabad, India. 
  24. Data-Based Medicine v/s Evidence Based Medicine at Indo-Global Healthcare Summit & Expo 2015. 23 – 26 July, 2015, Hyderabad, India. 
  25. The Emerging Role of Patient-Reported Outcomes (PROs) in Clinical Trials in India at ISPOR 20th Annual International Meeting, May 16 – 20, 2015, Philadelphia, PA, USA. 
  26. Electronic Health Record System in India: Implications for Health Technology Assessment (HTA), Status and Challenges. The Pharma Review 2014; 72-74
  27. Health Technology Assessment (HTA): Status & Future Challenges in India at Third International Conference of Pharmacoecomomics & Outcomes Research 2014. October 17 & 18, 2014. Organized by: ISPOR India Chapter. 
  28. Understanding the Era of “Digital Patient”: Are we ready to Achieve Better Healthcare Outcomes? at Third International Conference of Pharmacoecomomics & Outcomes Research 2014. October 17 & 18, 2014. Organized by: ISPOR India Chapter (Plenary Lecture) 
  29. Management of Clinical Trials in India – Current Perspective and Way Forward. The Pharma Review. 2013: 95-100